Indo Us Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 570.7 million compared to INR 436.35 million a year ago. Revenue was INR 571.79 million compared to INR 436.39 million a year ago. Net income was INR 77.27 million compared to INR 44.68 million a year ago. Basic earnings per share from continuing operations was INR 3.85 compared to INR 4.46 a year ago. Diluted earnings per share from continuing operations was INR 3.85 compared to INR 4.46 a year ago.